...
首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
【24h】

Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.

机译:在大便隐血试验中增加家族风险评估可以提高基于人群的大肠癌筛查的有效性。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The Dutch Health Council recently recommended the introduction of a colorectal cancer (CRC) screening programme by faecal occult blood testing (FOBT) for individuals aged 55-75 at population risk of CRC. Individuals at an increased familial CRC risk (>/= 2 times population risk) should be identified at a younger age, so they and their relatives can receive earlier, more intensive surveillance instead of FOBT. AIMS: To determine the percentage of participants with a positive FOBT in a CRC screening programme with an increased familial CRC risk. METHODS: In a population-based study, 10,569 individuals aged 50-75 received an FOBT. Individuals with a positive FOBT were invited for colonoscopy and familial risk assessment. Participants with an average familial CRC risk were compared to those with an increased risk. Increased familial CRC risk was defined as a cumulative lifetime risk of CRC of at least 10%. RESULTS: Of 6001 participants, 430 had a positive FOBT, of whom 324 (63% males; mean age 63 years) completed colonoscopy and familial risk assessment. CRC (n=22) and/or advanced adenomas (n=122) were found in 133 participants. Familial CRC risk was increased in 6% of participants with a positive FOBT. No significant differences were found between participants with an average versus an increased familial CRC risk. CONCLUSION: Six percent of participants with a positive FOBT had an increased familial CRC risk. Identifying at-risk participants enables them and their relatives to undergo regular colonoscopies. Adding familial risk assessment to FOBT screening may thus prevent a substantial number of CRCs.
机译:背景:荷兰卫生委员会最近建议通过粪便潜血测试(FOBT)引入大肠癌(CRC)筛查程序,该程序适用于55-75岁有CRC风险的人群。应确定家族性CRC风险增高(> / =人口风险的2倍)的个人,以便其及其亲属可以接受更早,更密集的监护,而不是FOBT。目的:确定家族性CRC风险增加的CRC筛查项目中FOBT阳性的参与者的百分比。方法:在一项基于人群的研究中,有10,569名年龄在50-75岁之间的人接受了FOBT。 FOBT阳性的个体被邀请进行结肠镜检查和家族风险评估。将平均家族性CRC风险的参与者与风险增加的参与者进行比较。家族性CRC风险增加的定义是,CRC的终生累积风险至少为10%。结果:在6001名参与者中,有430名FOBT阳性,其中324名(63%男性;平均年龄63岁)完成了结肠镜检查和家族风险评估。在133名参与者中发现了CRC(n = 22)和/或晚期腺瘤(n = 122)。 FOBT阳性的参与者中,家族性CRC风险增加了6%。平均和家族性CRC风险增加的参与者之间没有发现显着差异。结论:FOBT阳性的参与者中有6%的家族性CRC风险增加。识别高风险参与者可以使他们及其亲属定期进行结肠镜检查。因此,在FOBT筛查中增加家族风险评估可能会预防大量CRC。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号